Artificial intelligence (AI) is rapidly transforming oncology – from earlier and more accurate diagnoses to unlocking complex disease biology at the single-cell level.
In this conversation, Joe Day, senior business development executive (data/AI) at Cancer Research Horizons, speaks with Technology Networks about the most exciting developments in AI-powered cancer research, the critical importance of diverse, high-quality data and what it takes to build patient trust. Day also shares insights into ethical challenges, real-time model refinement and why involving patients at every step of the AI development journey is essential for ensuring impact and equity.
Read the ARTICLE ON TECHNOLOGY NETWORKS
